RPG Life Sciences Limited (BOM:532983)
1,997.35
-18.30 (-0.91%)
At close: Apr 21, 2026
RPG Life Sciences Market Cap
RPG Life Sciences has a market cap or net worth of 33.06 billion as of April 22, 2026. Its market cap has decreased by -12.23% in one year.
Market Cap
33.06B
Enterprise Value
30.82B
Revenue
6.74B
Ranking
n/a
PE Ratio
16.31
Stock Price
1,997.35
Market Cap Chart
Since June 10, 2008, RPG Life Sciences's market cap has increased from 645.16M to 33.06B, an increase of 5,023.76%. That is a compound annual growth rate of 24.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 33.32B | -13.24% |
| Dec 31, 2025 | 38.41B | 6.31% |
| Dec 31, 2024 | 36.13B | 63.53% |
| Dec 29, 2023 | 22.09B | 57.71% |
| Dec 30, 2022 | 14.01B | 37.00% |
| Dec 31, 2021 | 10.23B | 67.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 58.39B |
| Gufic Biosciences | 30.22B |
| Bliss GVS Pharma | 27.33B |
| Unichem Laboratories | 24.70B |
| Novartis India | 24.55B |
| Hikal | 23.69B |
| Morepen Laboratories | 22.97B |
| Kwality Pharmaceuticals | 18.13B |